WUKOMNI

Serial Number 97447038
606

Registration Progress

Application Filed
Jun 7, 2022
Under Examination
Sep 12, 2023
Approved for Publication
Jul 18, 2023
Published for Opposition
Jul 18, 2023
Registered

Trademark Image

WUKOMNI

Basic Information

Serial Number
97447038
Filing Date
June 7, 2022
Published for Opposition
July 18, 2023
Abandonment Date
April 15, 2024
Drawing Code
3

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Apr 15, 2024
Classes
005

Rights Holder

Dizal (Jiangsu) Pharmaceutical Co., Ltd.

03
Address
Room 4105, building E (No. 5), Huirong
Business Plaza, Jinghui E Rd. Xinwu Dist
Wuxi City, Jiangsu, .
CN

Ownership History

Dizal (Jiangsu) Pharmaceutical Co., Ltd.

Original Applicant
03
Wuxi City, Jiangsu, CN

Dizal (Jiangsu) Pharmaceutical Co., Ltd.

Owner at Publication
03
Wuxi City, Jiangsu, CN

Legal Representation

Attorney
Michael T. Smith

USPTO Deadlines

All Deadlines Cleared

All 5 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

17 events
Date Code Type Description Documents
Apr 15, 2024 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Apr 15, 2024 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Sep 12, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jul 18, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jul 18, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jun 28, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jun 15, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 2, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jun 1, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jun 1, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Mar 22, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Mar 22, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 22, 2023 GNRT F NON-FINAL ACTION E-MAILED Loading...
Mar 22, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jun 17, 2022 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Jun 16, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jun 10, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Acids for pharmaceutical purposes; adjuvants for medical purposes; agricultural fungicide; aluminum acetates for pharmaceutical purposes; amino acids for medical purposes; analgesics; anti-allergic and pain reduction medicines for treatment of illnesses for human purposes; antibiotic, sunburn and anti-inflammatory ointments for pharmaceutical purposes; antibiotics; antioxidant pills for medical use; antiseptics; astringents for medical purposes; bacterial culture mediums; bacterial poisons; bacterial preparations for medical purposes for researching of human illnesses; bacteriological research preparation, namely, preparations of reports for anti-tumor treatment for medical purposes; balsamic preparations for medical purposes; biological agents for the treatment of cancer; biological preparations for medical purposes for treatment of human illnesses; biological tissue cultures for medical purposes; blood for medical purposes; blood plasma; bouillons for bacteriological cultures; bronchodilating preparations; by-products of the processing of cereals for dietetic or medical purposes; cachets in the nature of capsules for medicinal preparations for the mouth for pharmaceutical purposes; candy for medical purposes; candy for pharmaceutical purpose for treatment of the cough; capsules made of dendrimer-based polymers for medicinal preparations for the mouth, for pharmaceuticals purposes; cellulose esters for pharmaceutical purposes; cellulose ethers for pharmaceutical purposes; chemical preparations as medicines for medical purposes, namely, for anti-tumor treatment; chemical preparations for pharmaceutical purposes for the treatment of human illnesses, namely, anti-tumor treatment; chemical reagents for medical purposes for the treatment of human illnesses; chemico-pharmaceutical preparations for treatment of human illnesses, namely, anti-tumor treatment; chewing gum for medical purposes; Chinese medicine nostrum for the treatment of tumors in humans; collyrium; contact lens cleaning preparations; contact lens disinfectant; contact lenses care solution; cough pastilles for pharmaceutical purposes; crystallized rock sugar for medical purposes; depuratives for the body; diagnostic biomarker reagents for medical purposes; diagnostic preparations for medical purposes; dietetic beverages adapted for medical purposes; dietetic foods adapted for medical purposes; dietetic substances of low sugar and salt adapted for medical use; digestives for pharmaceutical purposes; drugs for medical purposes for treatment of human illnesses, namely, anti-tumor treatment; enzyme preparations for medical purposes; enzymes for medical purposes; esters for pharmaceutical purposes; ethers for pharmaceutical purposes; eye drops; filled portable medicine cases, comprised of pharmaceuticals for treatment of human illnesses, namely, anti-tumor treatment; first-aid boxes, filled; fungicides; gelatine for medical purposes, namely, gelatin capsules sold empty; germicides; herbal teas for medicinal purposes; insect killing preparations in the nature of pesticides; insecticidal veterinary washes; insecticides; isotopes for medical purposes; media for bacteriological cultures; medical diagnosis reagent; medical probiotic supplements; medicated eye-washes; medicated lozenges for pharmaceutical purposes; medicinal drinks; medicinal hair growth preparations; medicinal preparations for the mouth to be applied in the form of capsules; medicines for alleviating constipation; medicines for dental purposes; mineral, bath and sodium salts for medical purposes; ophthalmic pharmaceutical products for anti-tumor treatment; ophthalmic preparations; opotherapy preparations; organotherapy preparations; pesticides; petroleum jelly for medical purposes; pharmaceutical blood preparations, namely, a blood clotting aid and delivery system for use in human medicine; pharmaceutical preparation for application to the eye or intraocular surgery for the purpose of anti-tumor treatment; pharmaceutical preparations for skin care; pharmaceutical preparations for treatment of human illnesses, namely, anti-tumor treatment; pharmaceutical preparations, namely, elixirs for anti-tumor treatment; phytotherapy preparations for medical purposes; pre-filled syringes of medicines for medical treatment purposes, namely, anti-tumor treatment; preparations for destroying noxious animals; protein dietary supplements; radioactive substances for medical purposes; radiological contrast substances for medical purposes; rat poison; raw material drugs, namely, pharmaceuticals for anti-tumor treatment; reagent paper for medical purposes; reagent paper for veterinary purposes; rubbing alcohol; solutions for contact lenses; stem cells for medical purposes; sterilizing preparations; styptic preparations; tonics being pharmaceutical preparations for the treatment of human illnesses, namely, anti-tumor treatment; vaccine preparations; bacteriological preparations for veterinary use; cultures of microorganisms for veterinary use; chemical reagents for veterinary purposes; veterinary preparations for the treatment of intestinal bacteria; diagnostic preparations for veterinary use

Additional Information

Design Mark
The mark consists of the literal element "WUKOMNI" to the right of a design consisting of two pairs of differing fanciful geometric shapes intended to depict a gene mutation process.
Color Claim
Color is not claimed as a feature of the mark.
Translation
The wording WUKOMNI has no meaning in a foreign language.

Classification

International Classes
005